Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;20(3):171-7.
doi: 10.1016/j.semradonc.2010.01.005.

Improving radiation conformality in the treatment of non-small cell lung cancer

Joe Y Chang  1 , James D Cox
Affiliations
Review

Improving radiation conformality in the treatment of non-small cell lung cancer

Joe Y Chang et al. Semin Radiat Oncol. 2010 Jul.

Abstract

One of the many challenges of lung cancer radiotherapy is conforming the radiation dose to the target due to tumor/organ motion and the need to spare surrounding critical structures. Evolving radiotherapy technologies, such as four-dimensional (4-D) image-based motion management, daily on-board imaging and adaptive radiotherapy, have enabled us to improve the therapeutic index of radiation therapy for lung cancer by permitting the design of personalized treatments that deliver adequate doses conforming to the target while sparing the surrounding critical normal tissues. Four-dimensional computed tomography (CT) image-based motion management provides an opportunity to individualize target motion margins and reduce the risk of a geographical target miss. Daily on-board imaging and adaptive radiotherapy reduce set-up and motion/anatomy uncertainties over the course of radiotherapy. These achievements in image guidance have permitted the implementation in lung cancer patients of highly conformal treatment delivery techniques that are exquisitely sensitive to organ motion and anatomic change such as intensity-modulated radiation therapy, stereotactic body radiation therapy, and proton therapy. More clinical studies are needed to further optimize conformal radiotherapy using individualized treatment adaptations based on changes in anatomy and tumor motion during the course of radiotherapy and using functional and biological imaging to selectively escalate doses to radioresistant subregions within the tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PET image-guided dose-painting to 74 Gy in region with SUV>13.8 using IMRT to improve biological conformality while keeping rest of target volume in 60 Gy to keep normal lung within dose volume constraint in stage IIIB NSCLC with contra-lateral mediastinal/hilar lymph node involvement.
Figure 2
Figure 2
Conformal ablative SBRT (50 Gy in 4 fractions) sparing surrounding critical structures in a tumor near the spinal cord (SC), bronchial tree (BT), esophagus (E), heart (H) and aorta (A). Color wash dose distributions are shown with corresponding scales.
Figure 3
Figure 3
Improving conformality from 3-DCRT to IMRT, PSPT and IMPT in a stage III B NSCLC with a complicated anatomy. IMPT provided optimal target coverage while sparing critical structures including spinal cord, esophagus, heart and lung.
See this image and copyright information in PMC

References

    1. Curran W, Scott C, Langer C, et al. Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresectable NSCLC:RTOG 9410. Proc Am Soc Clin Oncol. 2003;22:621a.
    1. Socinski M, Rosenman J, Halle J, et al. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B non-small cell lung carcinoma. Cancer. 2001;92:1213–1223. - PubMed
    1. Schild S, McGinnis W, Graham D, et al. Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:1106–1111. - PubMed
    1. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:117–125. - PubMed
    1. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma clinical outcome in 245 subjects in a Japanese multi-institutional study. Cancer. 2004;101:1623–1631. - PubMed

Publication types

MeSH terms